It’s Official: Topamax doesn’t work for Bipolar Disorder
The Carlat Psychiatry Report, Volume 5, Number 1, January 2007
https://www.thecarlatreport.com/newsletter-issue/tcprv5n1/
Issue Links: Learning Objectives | Editorial Information
Topics: Bipolar Disorder
David Fassler, MD
It’s been a bad, bad year for Topamax (topiramate). First, the results of four controlled trials of Topamax as monotherapy for mania showed that it outperforms placebo in only two ways: more paresthesia and more weight loss (Kushner et al, Bipolar Disorders 2006;8:15-27).
You can't view details of this content, please login or buy subscription here
David Fassler, MD
Clinical Professor of Psychiatry University of Vermont College of Medicine
Dr. Fassler discloses that he has no relationships with commercial entities related to the content of this educational activity.